BIOLOGIC OPTIMIZATION

Biologic Optimization
for Shoulder Injuries

Interest in biologic therapies has grown rapidly over the past decade. Patients frequently ask about platelet-rich plasma (PRP), peptides such as BPC-157 and TB-500, stem cells, exosomes, and other regenerative treatments. Some of these therapies are supported by promising laboratory and early clinical research, while others remain investigational and require further study.

Focus

Healing Biology

Role

Adjunctive Care

Evidence

Evolving

Goal

Optimize Recovery

Quick Answer

Biologic therapies aim to support the body's natural healing response. Some treatments, such as PRP, have been studied in human clinical trials for selected shoulder conditions. Others, including peptides like BPC-157 and TB-500, have shown encouraging laboratory and animal data but remain investigational for orthopedic use, with limited high-quality human evidence.

Current Evidence

Platelet-Rich Plasma (PRP): Moderate human evidence for selected tendon disorders; results vary by condition and preparation.

Peptides (BPC-157, TB-500): Encouraging laboratory and animal research; limited high-quality human clinical evidence for shoulder disorders; not FDA-approved for orthopedic indications.

Stem Cells & Exosomes: Active area of research, but evidence remains limited for routine clinical use in shoulder surgery.

What Is Biologic Optimization?

Biologic optimization refers to treatments intended to enhance the body's own healing response. Rather than replacing damaged tissue, these therapies are designed to influence inflammation, tissue repair, collagen formation, or cellular signaling. Depending on the condition, biologic therapies may be considered alongside rehabilitation, injections, or surgery—not necessarily instead of them.

Dr. Streit's Philosophy

I believe patients deserve balanced information. New biologic treatments are exciting, but enthusiasm should always be matched with scientific rigor. My goal is to discuss what is known, what remains uncertain, and how emerging therapies may fit into an individualized treatment plan.

Biologic Treatments We Review

Platelet-Rich Plasma (PRP)

Uses concentrated platelets from your own blood to deliver growth factors to injured tissue.

Peptides

Investigational compounds such as BPC-157 and TB-500 that are being studied for their potential role in tissue healing.

Stem Cells

Cell-based therapies under investigation for tendon, cartilage, and joint disorders.

Exosomes

Experimental biologic signaling particles currently being evaluated in regenerative medicine research.

Biologics After Surgery

Potential applications during postoperative recovery remain an active area of investigation.

Current Research

Review laboratory studies, clinical trials, and ongoing areas of investigation.

When Might Biologic Therapies Be Considered?

Rotator Cuff Disease

Tendinopathy

Partial Tendon Tears

Postoperative Recovery

Arthritis Symptoms

Clinical Research Participation

Frequently Asked Questions

What I Tell My Patients

"Biologic medicine is evolving quickly. Some therapies already have meaningful clinical evidence, while others remain experimental. The goal is to combine the best available science with individualized treatment decisions rather than relying on hype or marketing."

Continue Learning

Interested in Biologic Treatment Options?

Whether you are considering nonoperative care or recovering from shoulder surgery, we can discuss where biologic therapies may—or may not—fit into your individualized treatment plan based on the current evidence.

Request Consultation